Labs gear up to diagnose novel fungal infection April 15, 2019 -- Clinical laboratories are being advised by the U.S. Centers for Disease Control and Prevention on how to handle a relatively new fungal infection, Candida auris, that is detectable only with complex tests such as mass spectrometry, sequencing, and novel polymerase chain reaction assays. Discuss
Revenue from POC testing to outpace traditional IVD test market April 9, 2019 -- New in vitro diagnostic (IVD) tests capable of being performed at the point of care (POC) for patients are making major inroads. In a new report, market research firm Kalorama Information shares how growth in POC testing is outstripping the growth of more traditional lab-based IVD tests, and how the POC test market will produce $30 billion in sales globally by 2023. Discuss
Are commercial labs falling short in prenatal testing? April 3, 2019 -- A study published April 3 in Genetics in Medicine found that commercial laboratories offering noninvasive prenatal screening (NIPS) for genetic disorders were not meeting guidelines published by the American College of Medical Genetics and Genomics. The researchers surveyed 10 labs and found inconsistencies and inaccuracies in how they reported NIPS measures. Discuss
PerkinElmer launches genetic screening test April 3, 2019 -- PerkinElmer has launched GenePrism: Actionable Insights, a clinical-grade DNA test for genetic screening. GenePrism: Actionable Insights is designed to analyze all 59 ACMG genes in their entirety -- including BRCA1 and BRCA2, which have been associated with a higher risk of breast cancer
Blood test focuses on PlGF to diagnose pre-eclampsia April 2, 2019 -- A test that measures levels of placental growth factor (PlGF) in a woman's blood can be used to diagnose cases of pre-eclampsia, a potentially fatal complication of pregnancy, according to a study by U.K. researchers published April 1 in the Lancet. Discuss
Topol envisions AI to have wide-scale effect on genomics March 22, 2019 -- SAN JOSE, CA - Artificial intelligence (AI) is taking genomics to new heights -- pulling together and processing colossal amounts of genetic data at faster speeds, with better accuracy, and at lower overall costs, Dr. Eric Topol said in a March 19 talk at the GPU Technology Conference. Discuss
Micro-CT, blood test aid early lung cancer detection February 14, 2019 -- A blood test revealed that circulating DNA levels correlated with lung tumor size on micro-CT scans of mice, indicating the blood test's potential in the early detection of lung cancer, according to an article published online on 12 February in Disease Models & Mechanisms.
Liquid biopsy tracks response to lung cancer treatment February 13, 2019 -- Two recently published studies indicate that blood-based liquid biopsy can be used to track lung cancer treatment response by measuring levels of circulating tumor DNA in patients who are receiving treatments such as immunotherapy. Both studies found that liquid biopsy worked better than imaging-based methods. Discuss
Path lab firm to pay $64M penalty for referral payments February 1, 2019 -- Pathology laboratory company Inform Diagnostics has agreed to pay $63.5 million to settle allegations that it paid referring physicians for referrals, according to an announcement by the U.S. Department of Justice.